Julie-Anne Tanner1,2,3, Jennifer Hensel4, Paige E Davies3, Lisa C Brown5, Bryan M Dechairo6, Benoit H Mulsant7. 1. Tanenbaum Pharmacogenetics Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada. 2. Department of Psychiatry, University of Toronto, Ontario, Canada. 3. Assurex Health Ltd., Toronto, Ontario, Canada. 4. Department of Psychiatry, University of Manitoba, Winnipeg, Manitoba, Canada. 5. Myriad Neuroscience, Mason, OH, USA. 6. Myriad Genetics Inc., Salt Lake City, UT, USA. 7. Department of Psychiatry, University of Toronto, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Abstract
OBJECTIVES: To characterize the health-care utilization and economic burden associated with depression in Manitoba, Canada. METHODS: Patient-level data were retrieved from the Manitoba Centre for Health Policy administrative, clinical, and laboratory databases for the study period of January 1, 1996, through December 31, 2016. Patients were assigned to the depression cohort based on diagnoses recorded in hospitalizations and outpatient physician claims, as well as antidepressant prescription drug claims. A comparison cohort of nondepressed subjects, matched with replacement for age, gender, place of residence (urban vs. rural), and index date, was created. Demographics, comorbidities, intentional self-harm, mortality, health-care utilization, prescription drug utilization, and costs of health-care utilization and social services were compared between depressed patients and matched nondepressed patients, and incidence rate ratios and hazard ratios were reported. RESULTS: There were 190,065 patients in the depression cohort and 378,177 patients in the nondepression cohort. Comorbidities were 43% more prevalent among depressed patients. Intentional self-harm, all-cause mortality, and suicide mortality were higher among patients with depression than the nondepression cohort. Health-care utilization-including hospitalizations, physician visits, physician-provided psychotherapy, and prescription drugs-was higher in the depression than the nondepression cohort. Mean health-care utilization costs were 3.5 times higher among depressed patients than nondepressed patients ($10,064 and $2,832, respectively). Similarly, mean social services costs were 3 times higher ($1,522 and $510, respectively). Overall, depression adds a total average cost of $8,244 (SD = $40,542) per person per year. CONCLUSIONS: Depression contributes significantly to health burden and per patient costs in Manitoba, Canada. Extrapolation of the results to the entire Canadian health-care system projects an excess of $12 billion annually in health system spending.
OBJECTIVES: To characterize the health-care utilization and economic burden associated with depression in Manitoba, Canada. METHODS:Patient-level data were retrieved from the Manitoba Centre for Health Policy administrative, clinical, and laboratory databases for the study period of January 1, 1996, through December 31, 2016. Patients were assigned to the depression cohort based on diagnoses recorded in hospitalizations and outpatient physician claims, as well as antidepressant prescription drug claims. A comparison cohort of nondepressed subjects, matched with replacement for age, gender, place of residence (urban vs. rural), and index date, was created. Demographics, comorbidities, intentional self-harm, mortality, health-care utilization, prescription drug utilization, and costs of health-care utilization and social services were compared between depressedpatients and matched nondepressed patients, and incidence rate ratios and hazard ratios were reported. RESULTS: There were 190,065 patients in the depression cohort and 378,177 patients in the nondepression cohort. Comorbidities were 43% more prevalent among depressedpatients. Intentional self-harm, all-cause mortality, and suicide mortality were higher among patients with depression than the nondepression cohort. Health-care utilization-including hospitalizations, physician visits, physician-provided psychotherapy, and prescription drugs-was higher in the depression than the nondepression cohort. Mean health-care utilization costs were 3.5 times higher among depressedpatients than nondepressed patients ($10,064 and $2,832, respectively). Similarly, mean social services costs were 3 times higher ($1,522 and $510, respectively). Overall, depression adds a total average cost of $8,244 (SD = $40,542) per person per year. CONCLUSIONS:Depression contributes significantly to health burden and per patient costs in Manitoba, Canada. Extrapolation of the results to the entire Canadian health-care system projects an excess of $12 billion annually in health system spending.
Authors: Sujitha Ratnasingham; John Cairney; Heather Manson; Jürgen Rehm; Elizabeth Lin; Paul Kurdyak Journal: Can J Psychiatry Date: 2013-09 Impact factor: 4.356
Authors: Mel Slomp; Philip Jacobs; Arto Ohinmaa; Roger Bland; Ray Block; Carolyn S Dewa; Carina Wang Journal: Can J Psychiatry Date: 2012-09 Impact factor: 4.356
Authors: A N Freedman; L Wideroff; L Olson; W Davis; C Klabunde; K P Srinath; B B Reeve; R T Croyle; R Ballard-Barbash Journal: Am J Med Genet A Date: 2003-07-01 Impact factor: 2.802
Authors: Daniel V Vigo; Alan E Kazdin; Nancy A Sampson; Irving Hwang; Jordi Alonso; Laura Helena Andrade; Olatunde Ayinde; Guilherme Borges; Ronny Bruffaerts; Brendan Bunting; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Meredith G Harris; Elie G Karam; Georges Karam; Viviane Kovess-Masfety; Sing Lee; Fernando Navarro-Mateu; José Posada-Villa; Kate Scott; Juan Carlos Stagnaro; Margreet Ten Have; Chi-Shin Wu; Miguel Xavier; Ronald C Kessler Journal: Int J Ment Health Syst Date: 2022-06-23
Authors: Felipe Saia Tápias; Victor Henrique Oyamada Otani; Daniel Augusto Corrêa Vasques; Thais Zelia Santos Otani; Ricardo Riyoiti Uchida Journal: BMC Health Serv Res Date: 2021-05-06 Impact factor: 2.655
Authors: Carol A Hitchon; Randy Walld; Christine A Peschken; Charles N Bernstein; James M Bolton; Renée El-Gabalawy; John D Fisk; Alan Katz; Lisa M Lix; James Marriott; Scott B Patten; Jitender Sareen; Alexander Singer; Ruth Ann Marrie Journal: Arthritis Care Res (Hoboken) Date: 2021-01 Impact factor: 4.794
Authors: Yuri E Rybak; Ka S P Lai; Rajamannar Ramasubbu; Fidel Vila-Rodriguez; Daniel M Blumberger; Peter Chan; Nicholas Delva; Peter Giacobbe; Caroline Gosselin; Sidney H Kennedy; Hani Iskandar; Shane McInerney; Paula Ravitz; Verinder Sharma; Ari Zaretsky; Amer M Burhan Journal: Depress Anxiety Date: 2021-02-02 Impact factor: 6.505
Authors: Raymond Milan; Jacques LeLorier; Eric A Latimer; Marie-Josée Brouillette; Anne Holbrook; Ivan V Litvinov; Elham Rahme Journal: JAAD Int Date: 2022-06-25